Worg Pharma completes Series C financing
Worg Pharma announced the completion of over 1.1 billion RMB in Series C financing.
Read moreWorg Pharma announced the completion of over 1.1 billion RMB in Series C financing.
Read moreThe biopharmaceutical company Worg Pharma completes nearly 400 million RMB Series B financing
Read moreWorg Pharmaceuticals (Worg), a clinical stage biopharmaceutical company developing new treatments for allergic and autoi...
Read moreWorg won the "second prize" in Zhejiang Province in 2021 "maker China" and "Zhejiang good project" innovation and entrep...
Read moreExpands immunotherapy pipeline with potential first in class treatments for a range of autoimmune diseases
Read moreToday at the Entrepreneurship Competition Hangzhou 2021, Worg pharmaceuticals received the sole first prize of "Innovato...
Read moreInnovative pharmaceutical company Worg Pharma (“Worg”) and Global company with leading open-access biologics technology ...
Read more